Melissa R Snyder
Affiliation: Mayo Clinic
Willrich M, Murray D, Barnidge D, Ladwig P, Snyder M. Quantitation of infliximab using clonotypic peptides and selective reaction monitoring by LC-MS/MS. Int Immunopharmacol. 2015;28:513-20 pubmed publisher
..This approach has the potential to be quickly adaptable to other monoclonal antibodies and to expand the availability of testing for this class of therapeutics in routine clinical practice. ..
Donato L, Karras R, Katzmann J, Murray D, Snyder M. Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles. Respir Res. 2015;16:96 pubmed publisher
..Given the wide range of circulating wild-type protein observed in heterozygous patients, this method has the potential to reveal correlations between allele concentration and development and/or severity of clinical symptoms. ..
Willrich M, Murray D, Snyder M. Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases. Transl Res. 2015;165:270-82 pubmed publisher